Why AI Demos Die in Production (and How to Ship the Ones That Don't)

Almost every clinic AI project starts with a moment of magic. Someone plays a recorded consultation at a conference, a note appears, and the room goes quiet. It works. A three-year licence gets approved on the strength of that feeling.

Then it goes live, and the magic quietly dies. Two clinicians use it. The rest go back to typing. Six months later it is a line in the overhead that nobody defends and nobody quite cancels.

This is the most common failure in clinic AI, and it is almost never about the model.

The demo is the easy 20 percent

A demo only has to work once, on an encounter the vendor chose, in front of people who want to believe. A clinic has to work on the messy ninth patient of the afternoon, for a sceptical clinician running forty minutes late, when the chart is incomplete and the stakes are somebody’s health.

That is a completely different bar. The model was never the hard part. The hard part is everything around it.

What actually kills it: the last mile is trust

When we trace a dead AI feature back to its cause, it is almost always one of these:

• No way to verify. The tool drafts a note with nothing showing where each fact came from, so a careful clinician cannot check it in four seconds and has to re-read the whole thing. Careful clinicians are exactly the ones you were trying to help.
• No way to undo. If a mistake lands in a chart and cannot be cleanly pulled back, clinicians will not let software make it. They will route around it, politely, forever.
• No control. It acts when they wanted a suggestion, or suggests when they wanted it to just do the thing. The default is wrong and there is no dial.
• No fit. It lives in a separate tab instead of inside the EMR, so using it costs a context switch with a patient sitting there. That is not less effort, it is more.
• No feedback loop. It was right in March and slowly drifts, and nobody is sampling the twenty notes a month that would catch it.

Notice that none of these are solved by a better model. They are solved by design and engineering around the model.

A demo proves the model can do it. A clinic proves a clinician will let it near a chart.

Production-grade AI has a checklist

The features that survive contact with real users tend to share the same scaffolding:

1. Grounding and sources. Every fact points back to the chart entry it came from, with its date, so it can be checked in a glance rather than re-read.
2. Guardrails. Clear limits on what it will and will not do, with the risky actions gated.
3. A person in the loop by default. The clinician stays in control on a spectrum from suggest, to act-with-approval, to autonomous, and anything touching a chart never reaches the far end of it.
4. Reversibility. Anything it does can be reviewed and undone.
5. Evals. You define what good looks like on your own encounters before go-live and keep measuring it monthly after.
6. Native fit. It lives inside the EMR your staff already have open, removing clicks instead of adding a destination.

That list is unglamorous. It is also the entire difference between a feature that gets adopted and one that gets switched off.

The Tuesday test

The messy ninth patient A sceptical clinician An incomplete chart A Tuesday running late

Production scaffolding

Grounding, guardrails, human-in-the-loop, reversibility, evals, native UX

Adopted, not switched off

Design for adoption from day one

The mistake is treating adoption as a launch problem, something you worry about after the model works. By then the shape of the product is fixed and the trust gaps are baked in.

Adoption is a design problem, and for a practice it starts before the contract. Decide early where the clinician stays in control, how a draft gets verified in seconds, and what happens when it is wrong. Those decisions matter more to your outcome than which vendor you pick.

A test before you build

Before you sign anything, ask the vendor one question: when this is wrong, what happens, and who catches it?

If they have a clean answer, you are buying something that can live in a clinic. If they do not, you are buying a demo, and demos die quietly while the licence renews.

---

Been shown a demo you are not sure will survive your front desk? That is exactly the gap we design across. Book a free consult and we will map one low-cost, high-impact win for your practice, designed to be adopted rather than admired. See more on Second Opinion.